Scarica l'app Stockscreener
23.19
0.09%
0.02
Dopo l'orario di chiusura:
23.19
Precedente Chiudi:
$23.17
Aprire:
$23.3
Volume 24 ore:
567.11K
Relative Volume:
0.55
Capitalizzazione di mercato:
$2.97B
Reddito:
$2.89B
Utile/perdita netta:
$-33.80M
Rapporto P/E:
-85.89
EPS:
-0.27
Flusso di cassa netto:
$204.10M
1 W Prestazione:
-1.78%
1M Prestazione:
+0.78%
6M Prestazione:
+5.94%
1 anno Prestazione:
-10.57%
Intervallo 1D:
$23.03
$23.34
Intervallo di 1 settimana:
$22.91
$23.66
Portata 52W:
$19.50
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
Nome
Surgery Partners Inc
Settore
Industria
Telefono
615-234-5900
Indirizzo
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Confronta SGRY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
23.19 | 2.92B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
384.34 | 91.09B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
171.46 | 15.44B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
121.54 | 12.10B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
189.39 | 12.31B | 16.08B | 1.20B | 1.06B | 17.82 |
|
DVA
Davita Inc
|
137.90 | 10.30B | 12.82B | 936.34M | 1.47B | 10.74 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-16 | Iniziato | BofA Securities | Buy |
| 2024-10-14 | Iniziato | UBS | Buy |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Iniziato | Macquarie | Outperform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2023-11-14 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-05-12 | Iniziato | Mizuho | Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-06-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-01-10 | Ripresa | Citigroup | Buy |
| 2021-11-30 | Iniziato | Barclays | Overweight |
| 2021-11-29 | Aggiornamento | Stifel | Hold → Buy |
| 2021-11-01 | Iniziato | JP Morgan | Neutral |
| 2021-10-18 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-06-23 | Ripresa | Stifel | Hold |
| 2020-09-17 | Reiterato | The Benchmark Company | Buy |
| 2020-04-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Reiterato | The Benchmark Company | Buy |
| 2018-11-16 | Iniziato | UBS | Neutral |
| 2018-09-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Aggiornamento | Stifel | Sell → Hold |
| 2018-01-30 | Reiterato | The Benchmark Company | Buy |
| 2017-11-01 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Downgrade | Stifel | Hold → Sell |
| 2017-04-24 | Reiterato | Stifel | Hold |
| 2017-03-10 | Downgrade | Stifel | Buy → Hold |
| 2017-01-31 | Iniziato | The Benchmark Company | Buy |
| 2016-06-10 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-10-27 | Iniziato | Stifel | Buy |
| 2015-10-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-10-26 | Iniziato | Raymond James | Strong Buy |
Mostra tutto
Surgery Partners Inc Borsa (SGRY) Ultime notizie
Learn to Evaluate (SGRY) using the Charts - news.stocktradersdaily.com
Surgery Partners Sees 8.2% Sales Growth in Q1 2025 Amid Revenue MissNews and Statistics - IndexBox
SGRY Q1 Earnings Call: Volume Growth and Business Mix Shape Outlook Amid Margin Pressures - Yahoo Finance
UBS maintains buy rating for Surgery Partners stock amid AMSURG sale - Investing.com Canada
Surgery Partners gains amid report of AMSURG sale process - MSN
Vicarious Surgical Partners with UMass Memorial to Advance Robotic Surgery - The Healthcare Technology Report.
Surgery Partners Inc (SGRY) Trading 4.94% Higher on May 30 - GuruFocus
Cantor Fitzgerald maintains Overweight on Surgery Partners shares By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains Overweight on Surgery Partners shares - Investing.com
Assessing Surgery Partners: Insights From 4 Financial Analysts - Benzinga
Barclays Maintains Equal Weight Rating on Surgery Partners (SGRY), Cuts PT - MSN
Surgery Partners (SGRY) Target Price Lowered by Barclays | SGRY Stock News - GuruFocus
Surgery Partners price target lowered to $24 from $25 at Barclays - TipRanks
Surgery Partners (SGRY) Faces Price Target Reduction by Barclays | SGRY Stock News - GuruFocus
Long Term Trading Analysis for (SGRY) - news.stocktradersdaily.com
Q1 Earnings Highlights: Surgery Partners (NASDAQ:SGRY) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
Surgery Partners (SGRY) Shares Climb Amid AMSURG Sale Speculatio - GuruFocus
Surgery Partners reiterates 2025 guidance, targets $3.3B–$3.45B revenue while expanding high acuity and de novo growth - MSN
Surgery Partners stock gains amid report of AMSURG sale process - Seeking Alpha
Decoding Surgery Partners Inc (SGRY): A Strategic SWOT Insight - GuruFocus
Commit To Purchase Surgery Partners At $20, Earn 30.4% Annualized Using Options - Nasdaq
Investor Network: Surgery Partners, Inc. to Host Earnings Call - ACCESS Newswire
Northern Trust Corp Acquires 15,657 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
The Manufacturers Life Insurance Company Decreases Stock Position in Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
Surgery Partners stock holds Buy rating, $35 target from Benchmark By Investing.com - Investing.com Canada
Leerink cuts Surgery Partners target to $34, keeps Outperform rating By Investing.com - Investing.com Nigeria
Leerink cuts Surgery Partners target to $34, keeps Outperform rating - Investing.com
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2025 Earnings Call Transcript - Insider Monkey
Surgery Partners Inc (SGRY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Surgery Partners Inc (SGRY) Q1 2025 Earnings Call Highlights: St - GuruFocus
Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Surgery Partners (SGRY) Misses Q1 Earnings Expectations - GuruFocus
Surgery Partners (SGRY) Reports Q1 2025 Growth in Revenue and Su - GuruFocus
Surgery Partners Reports Q1 Revenue Growth and Reaffirms 2025 Outlook - TipRanks
Surgery Partners Inc. Reports Strong Growth Amid Challenges - TipRanks
Surgery Partners Inc Reports Q1 2025 Results: EPS Misses at -$0. - GuruFocus
Surgery Partners: Q1 Earnings Snapshot - MySA
Surgery Partners Misses Q1 Marks But Sticks To 2025 OutlookSurgery Partners (NASDAQ:SGRY) - Benzinga
Surgery Partners Inc earnings missed by $0.04, revenue fell short of estimates - Investing.com Nigeria
Earnings call transcript: Surgery Partners Q1 2025 results show mixed performance - Investing.com
Surgery Partners Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Surgery Partners Reaffirms FY25 OutlookUpdate - Nasdaq
Surgery Partners (SGRY) Q1 Earnings and Revenues Miss Estimates - Yahoo Finance
Surgery Partners, Inc. Announces First Quarter 2025 Results; Rea - GuruFocus
Surgery Partners (SGRY) Begins 2025 with Strong Financial Perfor - GuruFocus
Surgery Partners (SGRY) Begins 2025 with Strong Financial Performance | SGRY Stock News - GuruFocus
Why Surgery Partners Stock is Under Pressure - TipRanks
Surgery Partners Inc Azioni (SGRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Surgery Partners Inc Azioni (SGRY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Burkhalter Danielle | Chief Human Resources Officer |
Mar 14 '25 |
Sale |
23.78 |
74 |
1,760 |
44,839 |
| Webb William Trenton | American Group President |
Mar 14 '25 |
Sale |
23.70 |
138 |
3,271 |
74,521 |
0.01%
0.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):